228 related articles for article (PubMed ID: 23922695)
1. Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.
Nachbauer W; Boesch S; Schneider R; Eigentler A; Wanschitz J; Poewe W; Schocke M
PLoS One; 2013; 8(7):e69229. PubMed ID: 23922695
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.
Nachbauer W; Boesch S; Reindl M; Eigentler A; Hufler K; Poewe W; Löscher W; Wanschitz J
J Neuropathol Exp Neurol; 2012 Aug; 71(8):708-15. PubMed ID: 22805773
[TBL] [Abstract][Full Text] [Related]
3. Cellular bioenergetics after erythropoietin therapy in chronic renal failure.
Marrades RM; Alonso J; Roca J; González de Suso JM; Campistol JM; Barberá JA; Diaz O; Torregrosa JV; Masclans JR; Rodríguez-Roisin R; Wagner PD
J Clin Invest; 1996 May; 97(9):2101-10. PubMed ID: 8621800
[TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.
Nachbauer W; Hering S; Seifert M; Steinkellner H; Sturm B; Scheiber-Mojdehkar B; Reindl M; Strasak A; Poewe W; Weiss G; Boesch S
Cerebellum; 2011 Dec; 10(4):763-9. PubMed ID: 21597884
[TBL] [Abstract][Full Text] [Related]
5. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.
Lodi R; Rajagopalan B; Blamire AM; Cooper JM; Davies CH; Bradley JL; Styles P; Schapira AH
Cardiovasc Res; 2001 Oct; 52(1):111-9. PubMed ID: 11557239
[TBL] [Abstract][Full Text] [Related]
6. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP
Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in Friedreich ataxia.
Mariotti C; Nachbauer W; Panzeri M; Poewe W; Taroni F; Boesch S
J Neurochem; 2013 Aug; 126 Suppl 1():80-7. PubMed ID: 23859343
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia.
Lodi R; Hart PE; Rajagopalan B; Taylor DJ; Crilley JG; Bradley JL; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
Ann Neurol; 2001 May; 49(5):590-6. PubMed ID: 11357949
[TBL] [Abstract][Full Text] [Related]
10. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.
Lodi R; Cooper JM; Bradley JL; Manners D; Styles P; Taylor DJ; Schapira AH
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11492-5. PubMed ID: 10500204
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial impairment of human muscle in Friedreich ataxia in vivo.
Vorgerd M; Schöls L; Hardt C; Ristow M; Epplen JT; Zange J
Neuromuscul Disord; 2000 Aug; 10(6):430-5. PubMed ID: 10899450
[TBL] [Abstract][Full Text] [Related]
12. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.
Boesch S; Sturm B; Hering S; Scheiber-Mojdehkar B; Steinkellner H; Goldenberg H; Poewe W
Mov Disord; 2008 Oct; 23(13):1940-4. PubMed ID: 18759345
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
Mariotti C; Fancellu R; Caldarazzo S; Nanetti L; Di Bella D; Plumari M; Lauria G; Cappellini MD; Duca L; Solari A; Taroni F
Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
[TBL] [Abstract][Full Text] [Related]
14. Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.
Sturm B; Helminger M; Steinkellner H; Heidari MM; Goldenberg H; Scheiber-Mojdehkar B
Eur J Clin Invest; 2010 Jun; 40(6):561-5. PubMed ID: 20456483
[TBL] [Abstract][Full Text] [Related]
15. Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.
Nachbauer W; Wanschitz J; Steinkellner H; Eigentler A; Sturm B; Hufler K; Scheiber-Mojdehkar B; Poewe W; Reindl M; Boesch S
Mov Disord; 2011 Aug; 26(10):1935-8. PubMed ID: 21692115
[TBL] [Abstract][Full Text] [Related]
16. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease. Correlation with clinical and angiographic findings and comparison with healthy volunteers.
Schunk K; Romaneehsen B; Mildenberger P; Kersjes W; Schadmand-Fischer S; Thelen M
Invest Radiol; 1997 Nov; 32(11):651-9. PubMed ID: 9387051
[TBL] [Abstract][Full Text] [Related]
17. High-energy phosphate metabolism in the calf muscle of healthy humans during incremental calf exercise with and without moderate cuff stenosis.
Greiner A; Esterhammer R; Bammer D; Messner H; Kremser C; Jaschke WR; Fraedrich G; Schocke MF
Eur J Appl Physiol; 2007 Mar; 99(5):519-31. PubMed ID: 17206438
[TBL] [Abstract][Full Text] [Related]
18. Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.
Wolf C; Boesch S; Metzler B; Weirich-Schwaiger H; Trieb T; Schocke MF
Mol Imaging Biol; 2008; 10(1):24-9. PubMed ID: 18000714
[TBL] [Abstract][Full Text] [Related]
19. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
Kemp GJ; Meyerspeer M; Moser E
NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]